Rui Niimi

5PUBLICATIONS
15CO-AUTHORS
HaematologyPredictive and prognostic markersBiomechanical engineeringPharmaceutical delivery technologiesSpecial needs dentistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 01, 2026
Author response to the letter to the editor regarding "Hip Response to Romosozumab in Glucocorticoid Users: Beyond Systemic Bone Turnover Markers".

|May 08, 2026
Impact of oral glucocorticoids on the effectiveness of romosozumab: the multicenter OASIS cohort study.

|Apr 05, 2026
Baseline serum PINP is associated with early lumbar spine bone mineral density gains during twice-weekly teriparatide treatment: the OASIS cohort study.

Rui Niimi, Tomonori Kobayakawa, Yuki Etani

|Feb 12, 2026
Effectiveness of denosumab, teriparatide and romosozumab for glucocorticoid-induced osteoporosis: a propensity score-matched cohort study.

Toshitaka Yukishima, Tomonori Kobayakawa, Yuji Hirano

|Dec 13, 2017
Rebound-associated vertebral fractures after discontinuation of denosumab for the treatment of maxillitis.

R Niimi, T Kono, A Nishihara

Pageof 1

Frequent Collaborators

4 joint publications

Yuki Etani

4 joint publications

Takaaki Noguchi

4 joint publications

Seiji Okada

4 joint publications

Kosuke Ebina